{
    "id": 1858,
    "fullName": "BRCA1 C61G",
    "impact": "missense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "BRCA1 C61G lies within the RING-type zinc finger domain of the Brca1 protein (UniProt.org). C61G demonstrates retention of residual Brca1 activity in mouse models treated with DNA damaging agents (PMID: 22172724), but in other studies results in increased polyploidy and radiosensitivity in culture (PMID: 26246475), decreased Brca1 heterodimerization (PMID: 11278247), loss of ubiquitin ligase activity (PMID: 11278247, PMID: 16403807), loss of Bard1 and Ubch5a binding in vitro and in yeast (PMID: 30696104, PMID: 16403807), impaired single strand annealing repair (PMID: 23161852), and defective homologous recombination and HDR rescue (PMID: 20103620, PMID: 25823446), and therefore, is predicted to result in a loss of Brca1 protein function.",
            "references": [
                {
                    "id": 2497,
                    "pubMedId": 22172724,
                    "title": "BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22172724"
                },
                {
                    "id": 12146,
                    "pubMedId": 20103620,
                    "title": "Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20103620"
                },
                {
                    "id": 6028,
                    "pubMedId": 16403807,
                    "title": "Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16403807"
                },
                {
                    "id": 6124,
                    "pubMedId": 23161852,
                    "title": "Analysis of BRCA1 variants in double-strand break repair by homologous recombination and single-strand annealing.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23161852"
                },
                {
                    "id": 14788,
                    "pubMedId": 26246475,
                    "title": "Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26246475"
                },
                {
                    "id": 14801,
                    "pubMedId": 11278247,
                    "title": "The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11278247"
                },
                {
                    "id": 2576,
                    "pubMedId": 25823446,
                    "title": "Massively Parallel Functional Analysis of BRCA1 RING Domain Variants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25823446"
                },
                {
                    "id": 17217,
                    "pubMedId": 30696104,
                    "title": "GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30696104"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 672,
        "geneSymbol": "BRCA1",
        "terms": [
            "BRCA1",
            "BRCAI",
            "BRCC1",
            "BROVCA1",
            "FANCS",
            "IRIS",
            "PNCA4",
            "PPP1R53",
            "PSCP",
            "RNF53"
        ]
    },
    "variant": "C61G",
    "createDate": "09/23/2014",
    "updateDate": "01/17/2020",
    "referenceTranscriptCoordinates": {
        "id": 155521,
        "transcript": "NM_007294",
        "gDna": "chr17:g.43106487A>C",
        "cDna": "c.181T>G",
        "protein": "p.C61G",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2016,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, mouse breast cancer models harboring BRCA1 C61G with conditional loss of Tp53 had a decreased response to Lynparza (olaparib) compared to models with conditional loss of Brca1 and Tp53 (PMID: 22172724).",
            "molecularProfile": {
                "id": 4728,
                "profileName": "BRCA1 C61G TP53 loss"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 2497,
                    "pubMedId": 22172724,
                    "title": "BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22172724"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1828,
            "profileName": "BRCA1 C61G",
            "profileTreatmentApproaches": [
                {
                    "id": 17586,
                    "name": "PARP Inhibitor (Pan)",
                    "profileName": "BRCA1 C61G"
                },
                {
                    "id": 17587,
                    "name": "PARP-1 Inhibitor",
                    "profileName": "BRCA1 C61G"
                }
            ]
        },
        {
            "id": 4728,
            "profileName": "BRCA1 C61G TP53 loss",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 155524,
            "transcript": "NM_007298",
            "gDna": "chr17:g.43106487A>C",
            "cDna": "c.181T>G",
            "protein": "p.C61G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155522,
            "transcript": "NM_007300",
            "gDna": "chr17:g.43106487A>C",
            "cDna": "c.181T>G",
            "protein": "p.C61G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155523,
            "transcript": "NM_007299",
            "gDna": "chr17:g.43106487A>C",
            "cDna": "c.181T>G",
            "protein": "p.C61G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155521,
            "transcript": "NM_007294",
            "gDna": "chr17:g.43106487A>C",
            "cDna": "c.181T>G",
            "protein": "p.C61G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}